DTX200 FAQ's

Are peripheral as good as central/axial measurements?

The DTX-200 DexaCare® is patient friendly and easily accessible, even by handicapped, wheelchair, or stretcher-bound patients. It requires no special shielding or special room requirements.

The DTX-200 DexaCare® assesses forearm bone density with optimized precision and accuracy. It was developed on the background of over 20 years of research within the field of osteoporosis. The scanner quickly, precisely and accurately detects the 8mm distance between the radius and ulna and starts the measurement from that point to 24mm proximally every single time. This area correlates to the rest of the body as far as bone density without being affected by degenerative changes such as osteoarthritis. The accuracy at this site is better than 97%--the best available by any means.         The DTX-200 DexaCare® scans are 99% reproducible.

The excellent accuracy (>97%) and in vivo precision (>99%) makes the DTX-200 DexaCare® highly suitable for assessment of bone density and quantifiable follow-up. These numbers are equal or better than those of the central/ axial (table) systems. The DTX-200 DexaCare® is the only system to offer the patented "new Region of Interest" for follow-up assessment. This allows you to go to a precise site at the ultra-distal end of the radius and ulna and quantifiably measure the effectiveness of your treatment regimen in as little as 6-9 months. This results in better patient compliance and a way to assess their progress, before a change can be seen in the T-score (usually 18-24 months).  

What studies are available to verify the validity and efficacy of the DTX-200 DexaCare® system versus table systems?

"Bone Densitometry: A New, Highly Responsive Region of Interest in the Distal Forearm to Monitor the Effect of Osteoporosis Treatment" by P. Ravn, M.D., et al. "The Use of Forearm Bone Density Measurements in the Diagnosis of Osteoporosis and Assessment of Fracture Risk" by Sydney Lou Bonnick, M.D., FACP "Peripheral or Axial Bone Density Measurements?" by Glen M. Blake, PhD, et al

"Prevalence of Osteoporosis in Women Referred for Bone Density Testing; Utility of Multiple Skeletal Sites" by Dorothy A. Nelson, PhD et al Other references are available upon request.

What are the advantages of having the DTX-200 DexaCare® bone densitometer in my office versus sending my patients to the hospital or imaging center?

First of all you can offer a valuable new service to your patients in an environment that is well known to them - your office. This will make them feel more secure as opposed to sending them to a hospital or imaging center. You will be able to give the patient a clear answer within minutes and decide whether treatment is necessary or not. You can offer your patients savings in time and money by performing the procedure in your office. Patient compliance is enhanced when they see the results immediately for themselves and can consult with you about viable treatment options. Secondly, the DTX-200 DexaCare® will enable you to increase your practice revenue, increase referrals, and minimize your risk of losing a patient to someone else in your community who's doing the test. Studies have shown a satisfied patient refers 3.1 new patients to a practice and 30% of patients referred to another doctor don't return to their original provider.Type your paragraph here.

Who can perform the test in my office and how long does it take?

The DTX-200 DexaCare® is operator independent, i.e. it's very easy to understand, operate and has been designed in a way that minimizes operator errors. Practically anyone can be trained in a matter of hours. The measurement itself takes only 3 minutes. In the USA state regulations for x-ray services vary from state to state. Some states require the supervision of an x-ray technologist or physician; some states have no regulations. We can provide you with specific details for your state.

How will the DTX-200 DexaCare® system help my practice?

You will be able to offer your patients a valuable new service (and generate new revenue). Many patients have been with the same doctor for many years or haven't had a reason to return to their doctor. With your own DTX-200 DexaCare® you can provide bone density testing in a convenient, safe and familiar setting. There is a strong public awareness now of osteoporosis and a desire to prevent or treat it before a patient suffers a fracture or immobility.

Does insurance and Medicare cover bone densitometry? (USA)

Yes. The CPT code for the DTX-200 DexaCare® is 77081. There are over 40 ICD-9 codes applicable to this code depending upon the patient diagnosis. Most insurance companies are reimbursing 70-90% of the usual and customary billable rate. Of course, fee-for-service is a viable option.

e Medic

DTX-200 DexaCare®CPT Code 77081: Dual Energy X-ray Absorptiometry (DEXA) bone density study, one or more sites, appendicular skeleton (eg: radius, wrist, heel)
National Average Rate 2011:
Hospital Payment (facility APC 0655) - $32.11; Professional -$9.85

Global Payment (office and non hospital imaging center) - $28.88

The actual
reimbursement amount may vary depending on geographical location, payer, etc.

Check with your local carrier to make confirm local reimbursement amounts.

For the Medicare information for your state, please visit www.medicare.gov

How often is it covered? 
Medicare Part B (Medical Insurance) covers this test, which helps to see if you're at risk to broken bones, once every 24 months (more often if medically necessary) for people who meet the criteria below. Medicare only covers this test when it's ordered by a doctor or other qualified provider.

Who's eligible?
All qualified people with Medicare who are at risk for osteoporosis and meet one or more of these conditions:

A woman whose doctor determines she's estrogen deficient and at risk for osteoporosis, based on her medical history and other findings
A person whose X-rays show possible osteoporosis, osteopenia, or vertebral fractures
A person taking prednisone or steroid-type drugs or is planning to begin this treatment
A person who has been diagnosed with primary hyperparathyroidism
A person who is being monitored to see if their osteoporosis drug therapy is working

Your costs in Original Medicare.
You pay nothing for this test if the doctor or other qualified health care provider accepts assignment.